chartexchange

Rocket Lab stock jumped after earnings, but key risks points to a reversal

Invezz | Nov 16, 2026 9:05 AM EST

Rocket Lab stock has rebounded in the past few days as investors reacted to its earnings report, which showed that its revenue growth and backlog continued growing. RKLB jumped to a high of $67, its highest level since October 9. Still, the company could be at risk after SpaceX’s Starship launch. Rocket Lab published strong earnings RKLB stock jumped after the company published its financial results, which showed that its business continued to grow.  Rocket Lab’s revenue jumped by 73% in the third quarter as demand for its services soared. It made $268 million, with its backlog soaring by 52% to $3.6 billion. This backlog is spread across its key products like Electron, HASTE, and Neutron. For example, the company secured over $515 million in Neutron contracts from constellation operators. These contracts brought its backlog to 16 missions ahead of its launch.  Most notably, the company now expects that its revenue will keep growing over time. The company expects that its revenue will jump to between $270 million and $290 million, higher than the average estimate of $270 million. This guidance is notable because it excludes any Neutron revenue, which was expected to happen to start this quarter. In the earnings call, the management justified the Neutron delay to 2027 after it found voids in the propellant tanks forward dome.  The team has surged to manufacture a replacement part. After this is done, it will go through several stages to ensure that it is safe for launch. The view is that a premature launch would be more costly than the delay. In his statement, Peter Beck, the founder and CEO said: “The massive surge in Neutron bookings this quarter is the strongest signal yet of where the launch market is headed. We signed eight missions for roughly $515 million, with multiple flights sold at an elevated base price of $70 million per launch. Neutron's first 16 launches are booked.” Analysts are bullish but skeptical about RKLB stock Top analysts tracking the company are generally bullish on its stock, but have scaled down their targets until Neutron is up and running. Michael Filatov, a Berenberg Bank analyst maintained a bullish view and set a target of $85, up modestly from where it is today.  Kristine Liwag, a Morgan Stanley analyst, lowered his target from $105 to $103, while Needham’s Ryan Koontz, slashed the target from $120 to $100. Other analysts who slashed their targets are from Barclays, KeyCorp, Cantor Fitzgerald, and Piper Sandler. Most of these analysts believe that the company will need to prove that Neutron works.  Rocket Lab stock is reacting to the latest SpaceX rocket launch. The company caught part of its Starship rocket on return to earth, a move that will lower the cost of these launches.  Also, investors are waiting for the closing of the Iridium transaction. It has already raised the funds through a combination of debt and equity. Rocket Lab stock technical analysis RKLB stock chart | Source: TradingView The daily chart shows that the RKLB stock has been in a strong sell-off in the past few months, moving from a high of $151 in June to a low of $44.30. It recently dropped below the important support level of $58.20, the lower side of the head-and-shoulders pattern . A H&S pattern is one of the most common bearish reversal patterns in technical analysis. The stock has plunged below all moving averages and has retested the lower side of the H&S pattern. Therefore, there is a likelihood that the stock will resume the downward trend, potentially to this month’s low of $44.30. A move below that level will point to more downside.  The post Rocket Lab stock jumped after earnings, but key risks points to a reversal appeared first on Invezz

Read original article